Catalytic cleavage of HEAT and subsequent covalent binding of the tetralone moiety by the SARS-CoV-2 main protease

Abstract
Here we present the crystal structure of SARS-CoV-2 main protease (Mpro) covalently bound to 2-methyl-1-tetralone. This complex was obtained by co-crystallization of Mpro with HEAT (2-(((4-hydroxyphenethyl)amino)methyl)-3,4-dihydronaphthalen-1(2H)-one) in the framework of a large X-ray crystallographic screening project of Mpro against a drug repurposing library, consisting of 5632 approved drugs or compounds in clinical phase trials. Further investigations showed that HEAT is cleaved by Mpro in an E1cB-like reaction mechanism into 2-methylene-1-tetralone and tyramine. The catalytic Cys145 subsequently binds covalently in a Michael addition to the methylene carbon atom of 2-methylene-1-tetralone. According to this postulated model HEAT is acting in a pro-drug-like fashion. It is metabolized by Mpro, followed by covalent binding of one metabolite to the active site. The structure of the covalent adduct elucidated in this study opens up a new path for developing non-peptidic inhibitors.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
Subject Area
- Biochemistry (9559)
- Bioengineering (7075)
- Bioinformatics (24789)
- Biophysics (12577)
- Cancer Biology (9927)
- Cell Biology (14304)
- Clinical Trials (138)
- Developmental Biology (7934)
- Ecology (12084)
- Epidemiology (2067)
- Evolutionary Biology (15963)
- Genetics (10906)
- Genomics (14714)
- Immunology (9849)
- Microbiology (23595)
- Molecular Biology (9461)
- Neuroscience (50730)
- Paleontology (369)
- Pathology (1537)
- Pharmacology and Toxicology (2675)
- Physiology (4001)
- Plant Biology (8646)
- Synthetic Biology (2388)
- Systems Biology (6417)
- Zoology (1345)